Challenges assessing clinical endpoints in early Huntington disease

The primary aim of this study was to evaluate the current accepted standard clinical endpoint for the earliest-studied HD participants likely to be recruited into clinical trials. Since the advent of genetic testing for HD, it is possible to identify gene carriers prior to the diagnosis of disease,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Paulsen, Jane S., Wang, Chiachi, Duff, Kevin, Barker, Roger, Nance, Martha, Beglinger, Leigh, Moser, David, Williams, Janet K., Simpson, Sheila, Langbehn, Douglas, van Kammen, Daniel P.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2978744/
https://ncbi.nlm.nih.gov/pubmed/20623772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.23337
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items